Citations

Citations to this article as recorded by  

• Mitochondrial Dysfunction and Mitophagy in Type 2 Diabetes: Pathophysiology and Therapeutic Targets
  Nadezda Apostolova, Teresa Vezza, Jordi Muntane, Milagros Rocha, Víctor M. Víctor
  Antioxidants & Redox Signaling.2023; 39(4-6): 278.     CrossRef
• β Cell and Autophagy: What Do We Know?
  Hamid-Reza Mohammadi-Motlagh, Mona Sadeghalvad, Niloofar Yavari, Rosita Primavera, Setareh Soltani, Shashank Chetty, Abantika Ganguly, Shobha Regmi, Tina Fløyel, Simranjeet Kaur, Aashiq H. Mirza, Avnesh S. Thakor, Flemming Pociot, Reza Yarani
  Biomolecules.2023; 13(4): 649.     CrossRef
• The ameliorating effects of mesenchymal stem cells compared to α‐tocopherol on apoptosis and autophagy in streptozotocin‐induced diabetic rats: Implication of PI3K/Akt signaling pathway and entero‐insular axis
  Heba A. Mubarak, Manal M. Kamal, Yossra Mahmoud, Fatma S. Abd‐Elsamea, Eman Abdelbary, Marwa G. Gamea, Reham I. El‐Mahdy
  Journal of Cellular Biochemistry.2023; 124(11): 1705.     CrossRef
• Nutraceuticals as Modulators of Autophagy: Relevance in Parkinson’s Disease
  Michał Rakowski, Szymon Porębski, Agnieszka Grzelak
  International Journal of Molecular Sciences.2022; 23(7): 3625.     CrossRef
• High n-3 fatty acids counteract hyperglycemia-induced insulin resistance in fat-1 mice via pre-adipocyte NLRP3 inflammasome inhibition
  Qingyao Yu, Tiantian Wang, Feng Wang, Yong Yang, Canxia He, Wenge Yang, JinJie Zhang, Zuquan Zou
  Food & Function.2021; 12(1): 230.     CrossRef
• Metabolic and Metabolomic Insights Regarding the Omega-3 PUFAs Intake in Type 1 Diabetes Mellitus
  Carmen Purdel, Anca Ungurianu, Denisa Margina
  Frontiers in Molecular Biosciences.2021;[Epub]     CrossRef
• Effects of the linoleic acid/docosahexaenoic acid ratio and concentration inducing autophagy in Raw264.7 cells against Staphylococcus aureus
  Li-Ying Xu, Min Mu, Man-Li Wang, Jin-Cheng Liu, Yuan-Jie Zhou, Jing Wu, Bing-You Jiang, Ming-Gong Chen, Dong Hu, Xing-Rong Tao
  Journal of Clinical Biochemistry and Nutrition.2020; 67(2): 146.     CrossRef
• Free fatty acid receptor 3 differentially contributes to β-cell compensation under high-fat diet and streptozotocin stress
  Medha Priyadarshini, Connor Cole, Gautham Oroskar, Anton E. Ludvik, Barton Wicksteed, Congcong He, Brian T. Layden
  American Journal of Physiology-Regulatory, Integrative and Comparative Physiology.2020; 318(4): R691.     CrossRef
• Mitochondria and T2D: Role of Autophagy, ER Stress, and Inflammasome
  Milagros Rocha, Nadezda Apostolova, Ruben Diaz-Rua, Jordi Muntane, Victor M. Victor
  Trends in Endocrinology & Metabolism.2020; 31(10): 725.     CrossRef
• Omega-3 Polyunsaturated Fatty Acids Prevent Toxoplasma gondii Infection by Inducing Autophagy via AMPK Activation
  Choi, Lee, Lee, Park, Lee, Shin, Cha, Lee, Lim, Yuk
  Nutrients.2019; 11(9): 2137.     CrossRef
• Survivin regulated by autophagy mediates hyperglycemia-induced vascular endothelial cell dysfunction
  Yu-Xue Xu, Caoxin Huang, Minyi Liu, Ningning Chen, Wenting Chen, Chen Yang, Yan Zhao, Xuejun Li, Junguo Duan, Suhuan Liu, Shuyu Yang
  Experimental Cell Research.2018; 364(2): 152.     CrossRef
• Autophagy in Metabolic Age-Related Human Diseases
  Manon Moulis, Cecile Vindis
  Cells.2018; 7(10): 149.     CrossRef
• A comparison of the anti-diabetic potential of d-ribose-l-cysteine with insulin, and oral hypoglycaemic agents on pregnant rats
  Abraham A.A. Osinubi, Leke Jacob Medubi, Edidiong N. Akang, Lawal K. Sodiq, Titilola A. Samuel, Taiwo Kusemiju, James Osolu, Danladi Madu, Olufemi Fasanmade
  Toxicology Reports.2018; 5: 832.     CrossRef
• β-Cell Autophagy in Diabetes Pathogenesis
  Michelle R Marasco, Amelia K Linnemann
  Endocrinology.2018; 159(5): 2127.     CrossRef
• Endogenous synthesis of n-3 polyunsaturated fatty acids in fat-1 transgenic mice ameliorates streptozocin-induced diabetic nephropathy
  Yuan-Ming Zhang, Xiao-Hong Zhang, Pan Zhu, Rong-Hui Tan, Jin-Shun Zhao, Feng Wang, Jin-Jie Zhang, Wang Yan, Yang Xi, Jian-Bo Wan, Jing-Xuan Kang, Zu-Quan Zou, Shi-Zhong Bu
  Journal of Functional Foods.2018; 45: 427.     CrossRef
• PHLPP: a putative cellular target during insulin resistance and type 2 diabetes
  Alpana Mathur, Vivek Kumar Pandey, Poonam Kakkar
  Journal of Endocrinology.2017; 233(3): R185.     CrossRef
• Coenzyme Q10 ameliorates cerebral ischemia reperfusion injury in hyperglycemic rats
  Cui-Jie Lu, Yong-Zhen Guo, Yang Zhang, Lan Yang, Yue Chang, Jing-Wen Zhang, Li Jing, Jian-Zhong Zhang
  Pathology - Research and Practice.2017; 213(9): 1191.     CrossRef
• Changes in pancreatic histology, insulin secretion and oxidative status in diabetic rats following treatment with Ficus deltoidea and vitexin
  Samsulrizal Nurdiana, Yong Meng Goh, Hafandi Ahmad, Sulaiman Md Dom, Nur Syimal’ain Azmi, Noor Syaffinaz Noor Mohamad Zin, Mahdi Ebrahimi
  BMC Complementary and Alternative Medicine.2017;[Epub]     CrossRef
• Comparative analysis of the efficacy of omega-3 fatty acids for hypertriglyceridaemia management in Korea
  H.-S. Kim, H. Kim, Y. J. Jeong, S. J. Yang, S. J. Baik, H. Lee, S.-H. Lee, J. H. Cho, I.-Y. Choi, H. W. Yim, K.-H. Yoon
  Journal of Clinical Pharmacy and Therapeutics.2016; 41(5): 508.     CrossRef

Glucagon-like peptide-1 (GLP-1) is a gut-derived incretin hormone that increases glucose-stimulated insulin secretion in pancreatic β-cells. Since mitochondrial function is crucial to insulin secretion, we hypothesized that GLP-1 may increase mitochondrial biogenesis in pancreatic β-cells. We treated INS-1 rat insulinoma cells with GLP-1 or exendin-4 for 48 hours and measured mitochondrial mass and function. Both GLP-1 and exendin-4 increased mitochondrial mass by approximately 20%. The mitochondria/cytosol ratio was increased from 7.60±3.12% to 10.53±2.70% by exendin-4. In addition, GLP-1 increased the mitochondrial membrane potential and oxygen consumption. Proliferator-activated receptor-gamma coactivator 1α expression was increased approximately 2-fold by GLP-1 treatment. In conclusion, the present study presents evidence for a new mechanism of action by which GLP-1 improves pancreatic β-cell function via enhanced mitochondrial mass and performance.

Citations

Citations to this article as recorded by  

• New fraternine analogues: Evaluation of the antiparkinsonian effect in the model of Parkinson's disease
  Andréia Biolchi Mayer, Henrique de Oliveira Amaral, Danilo Gustavo R. de Oliveira, Gabriel Avohay Alves Campos, Priscilla Galante Ribeiro, Solange Cristina Rego Fernandes, Adolfo Carlos Barros de Souza, Raffael Júnio Araújo de Castro, Anamélia Lorenzetti
  Neuropeptides.2024; 103: 102390.     CrossRef
• Prospects of antidiabetic drugs in the treatment of neurodegenerative disease
  Lidan Hu, Wenmin Wang, Xiangjun Chen, Guannan Bai, Liangjian Ma, Xin Yang, Qiang Shu, Xuekun Li
  Brain‐X.2024;[Epub]     CrossRef
• Attenuating mitochondrial dysfunction and morphological disruption with PT320 delays dopamine degeneration in MitoPark mice
  Vicki Wang, Kuan-Yin Tseng, Tung-Tai Kuo, Eagle Yi-Kung Huang, Kuo-Lun Lan, Zi-Rong Chen, Kuo-Hsing Ma, Nigel H. Greig, Jin Jung, Ho-II Choi, Lars Olson, Barry J. Hoffer, Yuan-Hao Chen
  Journal of Biomedical Science.2024;[Epub]     CrossRef
• Targeting GLP-1 receptors to reduce nicotine use disorder: Preclinical and clinical evidence
  Rae J. Herman, Heath D. Schmidt
  Physiology & Behavior.2024; 281: 114565.     CrossRef
• Liraglutide demonstrates a therapeutic effect on mitochondrial dysfunction in human SGBS adipocytes in vitro
  Maija Vaittinen, Mariana Ilha, Elena Herbers, Anita Wagner, Kirsi A. Virtanen, Kirsi H. Pietiläinen, Eija Pirinen, Jussi Pihlajamäki
  Diabetes Research and Clinical Practice.2023; 199: 110635.     CrossRef
• The cardioprotective effect of human glucagon‐like peptide‐1 receptor agonist (semaglutide) on cisplatin‐induced cardiotoxicity in rats: Targeting mitochondrial functions, dynamics, biogenesis, and redox status pathways
  Marwa Mohamed Atef, Yasser Mostafa Hafez, Omnia Safwat El‐Deeb, Eman H. Basha, Radwa Ismail, Hanan Alshenawy, Rasha Osama El‐Esawy, Amira Kamel Eltokhy
  Cell Biochemistry and Function.2023; 41(4): 450.     CrossRef
• Targeting mitochondrial quality control for diabetic cardiomyopathy: Therapeutic potential of hypoglycemic drugs
  Yutong Zhou, Wendong Suo, Xinai Zhang, Jiaojiao Liang, Weizhe Zhao, Yue Wang, Hong Li, Qing Ni
  Biomedicine & Pharmacotherapy.2023; 168: 115669.     CrossRef
• Soft X-ray tomography to map and quantify organelle interactions at the mesoscale
  Valentina Loconte, Jitin Singla, Angdi Li, Jian-Hua Chen, Axel Ekman, Gerry McDermott, Andrej Sali, Mark Le Gros, Kate L. White, Carolyn A. Larabell
  Structure.2022; 30(4): 510.     CrossRef
• Comparisons of pleiotropic effects of SGLT2 inhibition and GLP-1 agonism on cardiac glucose intolerance in heart dysfunction
  Belma Turan, Aysegul Durak, Yusuf Olgar, Erkan Tuncay
  Molecular and Cellular Biochemistry.2022; 477(11): 2609.     CrossRef
• Modulation of Reactive Oxygen Species Homeostasis as a Pleiotropic Effect of Commonly Used Drugs
  Carolin Thomas, Lia Wurzer, Ernst Malle, Michael Ristow, Corina T. Madreiter-Sokolowski
  Frontiers in Aging.2022;[Epub]     CrossRef
• Anti-cancer effects of sitagliptin, vildagliptin, and exendin-4 on triple-negative breast cancer cells via mitochondrial modulation
  POOJA JAISWAL, VERSHA TRIPATHI, ANSHUL ASSAIYA, DHARMENDRA KASHYAP, RAHUL DUBEY, ANAMIKA SINGH, JANESH KUMAR, HEM CHANDRA JHA, RAJESH SHARMA, AMIT KUMAR DIXIT, HAMENDRA SINGH PARMAR
  BIOCELL.2022; 46(12): 2645.     CrossRef
• Effect of liraglutide on neural and peripheral markers of metabolic function during antipsychotic treatment in rats
  Ilijana Babic, Dominic Sellers, Paul L Else, Jessica Nealon, Ashleigh L Osborne, Nagesh Pai, Katrina Weston-Green
  Journal of Psychopharmacology.2021; 35(3): 284.     CrossRef
• Sustained Release GLP-1 Agonist PT320 Delays Disease Progression in a Mouse Model of Parkinson’s Disease
  Vicki Wang, Tung-Tai Kuo, Eagle Yi-Kung Huang, Kuo-Hsing Ma, Yu-Ching Chou, Zhao-Yang Fu, Li-Wen Lai, Jin Jung, Hoi-II Choi, Doo-Sup Choi, Yazhou Li, Lars Olson, Nigel H. Greig, Barry J. Hoffer, Yuan-Hao Chen
  ACS Pharmacology & Translational Science.2021; 4(2): 858.     CrossRef
• Antioxidative Potentials of Incretin-Based Medications: A Review of Molecular Mechanisms
  Habib Yaribeygi, Mina Maleki, Thozhukat Sathyapalan, Tannaz Jamialahmadi, Amirhossein Sahebkar, Marina Sokovi
  Oxidative Medicine and Cellular Longevity.2021; 2021: 1.     CrossRef
• Vernicia fordii (Hemsl.) Airy Shaw extract stimulates insulin secretion in pancreatic β-cells and improves insulin sensitivity in diabetic mice
  Jimin Hyun, Mi Hyeon Park, Yo Han Lee, Youngeun Lee, Su Ji Jeong, Sun Sil Choi, Keon Woo Khim, Hye Jin Eom, Jin-Hoe Hur, Chan Young Park, Jae-Ick Kim, Jiyoung Park, Hyung Won Ryu, Hyun-Jun Jang, Sei-Ryang Oh, Jang Hyun Choi
  Journal of Ethnopharmacology.2021; 278: 114238.     CrossRef
• Connecting the dots between mitochondrial dysfunction and Parkinson’s disorder: focus mitochondria-targeting therapeutic paradigm in mitigating the disease severity
  Ishnoor Kaur, Tapan Behl, Aayush Sehgal, Sukhbir Singh, Neelam Sharma, Lotfi Aleya, Simona Bungau
  Environmental Science and Pollution Research.2021; 28(28): 37060.     CrossRef
• Neuromodulatory effects of anti-diabetes medications: A mechanistic review
  Habib Yaribeygi, Milad Ashrafizadeh, Neil C. Henney, Thozhukat Sathyapalan, Tannaz Jamialahmadi, Amirhossein Sahebkar
  Pharmacological Research.2020; 152: 104611.     CrossRef
• Antidiabetic Agents for Treatment of Parkinson’s Disease: A Meta-Analysis
  Shu-Yi Wang, Shey-Lin Wu, Ta-Cheng Chen, Chieh-Sen Chuang
  International Journal of Environmental Research and Public Health.2020; 17(13): 4805.     CrossRef
• Visualizing subcellular rearrangements in intact β cells using soft x-ray tomography
  Kate L. White, Jitin Singla, Valentina Loconte, Jian-Hua Chen, Axel Ekman, Liping Sun, Xianjun Zhang, John Paul Francis, Angdi Li, Wen Lin, Kaylee Tseng, Gerry McDermott, Frank Alber, Andrej Sali, Carolyn Larabell, Raymond C. Stevens
  Science Advances.2020;[Epub]     CrossRef
• Nutrient Sensor mTOR and OGT: Orchestrators of Organelle Homeostasis in Pancreatic β-Cells
  Nicholas Esch, Seokwon Jo, Mackenzie Moore, Emilyn U. Alejandro, Yingke Xu
  Journal of Diabetes Research.2020; 2020: 1.     CrossRef
• Metabolic dynamics of human Sertoli cells are differentially modulated by physiological and pharmacological concentrations of GLP-1
  Ana D. Martins, Mariana P. Monteiro, Branca M. Silva, Alberto Barros, Mário Sousa, Rui A. Carvalho, Pedro F. Oliveira, Marco G. Alves
  Toxicology and Applied Pharmacology.2019; 362: 1.     CrossRef
• Sarcopenia in Chronic Kidney Disease: Factors, Mechanisms, and Therapeutic Interventions
  Hiroshi Watanabe, Yuki Enoki, Toru Maruyama
  Biological and Pharmaceutical Bulletin.2019; 42(9): 1437.     CrossRef
• Recent Advances in Drug Repurposing for Parkinson’s Disease
  Xin Chen, Giuseppe Gumina, Kristopher G. Virga
  Current Medicinal Chemistry.2019; 26(28): 5340.     CrossRef
• Mitochondrial dysfunction in diabetes and the regulatory roles of antidiabetic agents on the mitochondrial function
  Habib Yaribeygi, Stephen L. Atkin, Amirhossein Sahebkar
  Journal of Cellular Physiology.2019; 234(6): 8402.     CrossRef
• Liraglutide protects against glucolipotoxicity‐induced RIN‐m5F β‐cell apoptosis through restoration of PDX1 expression
  Edy Kornelius, Hsin‐Hua Li, Chiung‐Huei Peng, Yi‐Sun Yang, Wei‐Jen Chen, Yan‐Zin Chang, Yi‐Chiao Bai, Stanley Liu, Chien‐Ning Huang, Chih‐Li Lin
  Journal of Cellular and Molecular Medicine.2019; 23(1): 619.     CrossRef
• The osteogenic effect of liraglutide involves enhanced mitochondrial biogenesis in osteoblasts
  Subhashis Pal, Shailendra K. Maurya, Sourav Chattopadhyay, Shyamsundar Pal China, Konica Porwal, Chirag Kulkarni, Sabyasachi Sanyal, Rohit A. Sinha, Naibedya Chattopadhyay
  Biochemical Pharmacology.2019; 164: 34.     CrossRef
• Novel Treatment Opportunities Against Cognitive Impairment in Parkinson’s Disease with an Emphasis on Diabetes-Related Pathways
  Holly Green, Panagiota Tsitsi, Ioanna Markaki, Dag Aarsland, Per Svenningsson
  CNS Drugs.2019; 33(2): 143.     CrossRef
• Mitral cells and the glucagon‐like peptide 1 receptor: The sweet smell of success?
  Enrico Bagnoli, Una FitzGerald
  European Journal of Neuroscience.2019; 49(4): 422.     CrossRef
• Targeting the DPP-4-GLP-1 pathway improves exercise tolerance in heart failure patients: a systematic review and meta-analysis
  Chengcong Chen, Ying Huang, Yongmei Zeng, Xiyan Lu, Guoqing Dong
  BMC Cardiovascular Disorders.2019;[Epub]     CrossRef
• Acute exposure to 3‑deoxyglucosone at high glucose levels impairs insulin secretion from β‑cells by downregulating the sweet taste receptor signaling pathway
  Xiudao Song, Guoqiang Liang, Min Shi, Liang Zhou, Fei Wang, Lurong Zhang, Fei Huang, Guorong Jiang
  Molecular Medicine Reports.2019;[Epub]     CrossRef
• Translational approaches to restoring mitochondrial function in Parkinson's disease
  Heather Mortiboys, Ruby Macdonald, Thomas Payne, Matilde Sassani, Thomas Jenkins, Oliver Bandmann
  FEBS Letters.2018; 592(5): 776.     CrossRef
• Neuroprotective exendin-4 enhances hypothermia therapy in a model of hypoxic-ischaemic encephalopathy
  Eridan Rocha-Ferreira, Laura Poupon, Aura Zelco, Anna-Lena Leverin, Syam Nair, Andrea Jonsdotter, Ylva Carlsson, Claire Thornton, Henrik Hagberg, Ahad A Rahim
  Brain.2018; 141(10): 2925.     CrossRef
• Current perspective of mitochondrial biology in Parkinson's disease
  Navneet Ammal Kaidery, Bobby Thomas
  Neurochemistry International.2018; 117: 91.     CrossRef
• Humanin promotes mitochondrial biogenesis in pancreatic MIN6 β-cells
  Qingqing Qin, Jieqiong Jin, Fang He, Yongqin Zheng, Tingting Li, Yun Zhang, Jundong He
  Biochemical and Biophysical Research Communications.2018; 497(1): 292.     CrossRef
• Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial
  Dilan Athauda, Kate Maclagan, Simon S Skene, Martha Bajwa-Joseph, Dawn Letchford, Kashfia Chowdhury, Steve Hibbert, Natalia Budnik, Luca Zampedri, John Dickson, Yazhou Li, Iciar Aviles-Olmos, Thomas T Warner, Patricia Limousin, Andrew J Lees, Nigel H Grei
  The Lancet.2017; 390(10103): 1664.     CrossRef
• Alogliptin, a Dipeptidyl Peptidase‐4 Inhibitor, Alleviates Atrial Remodeling and Improves Mitochondrial Function and Biogenesis in Diabetic Rabbits
  Xiaowei Zhang, Zhiwei Zhang, Yungang Zhao, Ning Jiang, Jiuchun Qiu, Yajuan Yang, Jian Li, Xue Liang, Xinghua Wang, Gary Tse, Guangping Li, Tong Liu
  Journal of the American Heart Association.2017;[Epub]     CrossRef
• Potential therapeutic interventions for chronic kidney disease‐associated sarcopenia via indoxyl sulfate‐induced mitochondrial dysfunction
  Yuki Enoki, Hiroshi Watanabe, Riho Arake, Rui Fujimura, Kana Ishiodori, Tadashi Imafuku, Kento Nishida, Ryusei Sugimoto, Saori Nagao, Shigeyuki Miyamura, Yu Ishima, Motoko Tanaka, Kazutaka Matsushita, Hirotaka Komaba, Masafumi Fukagawa, Masaki Otagiri, To
  Journal of Cachexia, Sarcopenia and Muscle.2017; 8(5): 735.     CrossRef
• The pancreas: Bandmaster of glucose homeostasis
  Nathalie Jouvet, Jennifer L. Estall
  Experimental Cell Research.2017; 360(1): 19.     CrossRef
• The glucagon-like peptide 1 (GLP) receptor as a therapeutic target in Parkinson's disease: mechanisms of action
  Dilan Athauda, Thomas Foltynie
  Drug Discovery Today.2016; 21(5): 802.     CrossRef
• Effects of addition of a dipeptidyl peptidase IV inhibitor to metformin on sirolimus-induced diabetes mellitus
  Long Jin, Sun Woo Lim, Jian Jin, Byung Ha Chung, Chul Woo Yang
  Translational Research.2016; 174: 122.     CrossRef
• Pharmacological Modulators of Endoplasmic Reticulum Stress in Metabolic Diseases
  Tae Jung, Kyung Choi
  International Journal of Molecular Sciences.2016; 17(2): 192.     CrossRef